1) Relevance ratio of osteoporosis
骨质疏松检出率
3) prevalence of osteoporosis
骨质疏松发病率
1.
prevalence of osteoporosis was 6.
50-59岁年龄段骨质疏松发病率为6。
4) osteoporosis
[英][,ɔstiəʊpə'rəʊsɪs] [美]['ɑstɪopə'rosɪs]
骨质疏松
1.
Experimental Study of The Effect of OPGmRNA and RANKLmRNA about The method of Bu Shen Jian Pi on The Osteoporosis rat;
补肾健脾法对骨质疏松大鼠OPGmRNA、RANKLmRNA表达影响的实验研究
2.
Effects of Bushenfugai Traditional Chinese Medicine on morphometry of osteoporosis induced by ovary irradiation in rats;
补肾富钙中药对大鼠卵巢辐射损伤所致骨质疏松形态计量学的影响
3.
Progress in the research into the relationshipbetween osteoporosis and jaw implant;
骨质疏松症与颌骨种植体关系研究进展
5) osteoprosis
骨质疏松
1.
Health education for preventing osteoprosis fracture;
预防骨质疏松性骨折的健康教育
2.
Objective To investigate the action of insulin (INS), Bone Gla Proteinin (BGP) and parathyroid hormone(PTH) in pathogenesis of elderly Type 2 diabetes mellitus(T2DM) with Osteoprosis.
目的对老年2型糖尿病(type 2 diabetes mellitus,T2DM)合并骨质疏松(osteoprosis,OP)患者血胰岛素(insulin,INS)与骨钙素(osteocalcin,OC或Bone Gla Protein,BGP)及甲状旁腺素(parathyroid hormone,PTH)等进行研究,探讨它们在老年T2DM合并OP发病机理中的作用。
6) Bone mineral density
骨质疏松
1.
Purpose:To offer the scope of bone mineral density(BMD)for the osteoporosis in different age by quantitative CT in the senile.
结论 :骨质疏松与年龄呈正相关 ,不同年龄段的老年人应有其不同的骨密度CT参考值。
2.
Bone mineral density and bone metabolism\|associated biochemical markers were determined.
目的 探讨补肾方药对骨质疏松的防治作用及其机理。
补充资料：骨质疏松症
| 骨质疏松症 osteoporosis 由于各种原因引起的骨代谢障碍。主要表现为单位体积内骨量降低，骨基质有机成分及钙盐沉着均减少，但基本结构保持不变。临床表现主要为骨痛和骨折，以脊椎骨折、股骨颈骨折及桡骨远端骨折多见。X射线表现以骨皮质变薄及骨小梁减少为特征。骨密度测定常用光子吸收测量。防治的重点在于预防骨折的发生，老年要补充钙和性激素，降钙素可同时预防和治疗骨质疏松症。 |
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条